|
1
|
Ziff M: Rheumatoid arthritis-its present
and future. J Rheumatol. 17:127–133. 1990.PubMed/NCBI
|
|
2
|
Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju
JH, Min SY, Cho YG, Park SH and Kim HY: Human rheumatoid synovial
fibroblasts promote osteoclastogenic activity by activating RANKL
via TLR-2 and TLR-4 activation. Immunol Lett. 110:54–64. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bottini N and Firestein G: Duality of
fibroblast-like synoviocytes in RA: Passive responders and
imprinted aggressors. Nat Rev Rheumatol. 9:24–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Firestein GS: Evolving concepts of
rheumatoid arthritis. Nature. 423:356–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brenna FM and Mcinnes IB: Evidence that
cytokines play a role in rheumatoid arthritis. J Clin Invest.
118:3537–3545. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rose-John S, Scheller J, Elson G and Jones
SA: Interleukin-6 biology is coordinated by membrane-bound and
soluble receptors: Role in inflammation and cancer. J Leukoc Biol.
80:227–236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsu YH, Li HH, Hsieh MY, Liu MF, Huang KY,
Chin LS, Chen PC, Cheng HH and Chang MS: Function of interleukin-20
as a proinflammatory molecule in rheumatoid and experimental
arthritis. Arthritis Rheum. 54:2722–2733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chiang EY, Kolumam GA, Yu X, Francesco M,
Ivelja S, Peng I, Gribling P, Shu J, Lee WP, Refino CJ, et al:
Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17
cells inhibits autoimmune disease. Nat Med. 15:766–773. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu F, Shi L, Mu R, Zhu J, Li Y, Ma X, Li
C, Jia R, Yang D, Li Y and Li Z: Hypoxia-inducible factor-1a and
interleukin 33 form a regulatory circuit to perpetuate the
inflammation in rheumatoid arthritis. PLoS One. 8:e726502013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Liu Z, Zhuang G, Yin P, Tao H, Qiu
J, Hu Q and Zhang J: Anti-DR5 mAb ameliorate adjuvant arthritis
rats through inducing synovial cells apoptosis. Exp Biol Med
(Maywood). 234:1468–1476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun H, Gong S, Carmody RJ, Hilliard A, Li
L, Sun J, Kong L, Xu L, Hilliard B, Hu S, et al: TIPE2, a negative
regulator of innate and adaptive immunity that maintains immune
homeostasis. Cell. 133:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Freundt EC, Bidere N and Lenardo MJ: A
different TIPE of immune homeostasis. Cell. 133:401–402. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Wang J, Fan C, Li H, Sun H, Gong
S, Chen YH and Shi Y: Crystal structure of TIPE2 provides insights
into immune homeostasis. Nat Struct Mol Biol. 16:89–90. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Fayngerts S, Wang P, Sun H,
Johnson DS, Ruan Q, Guo W and Chen YH: TIPE2 protein serves as a
negative regulator of phagocytosis and oxidative burst during
infection. Proc Natl Acad Sci USA. 109:15413–15418. 2012;
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu MW, Su MX, Wang YH and Qian CY: Effect
of melilotus extract on lung injury via the upregulation of tumor
necrosis factor-a-induced protein-8-like 2 in septic mice. Mol Med
Rep. 11:1675–1684. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang LY, Fan YC, Zhao J, Gao S, Sun FK,
Han J, Yang Y and Wang K: Elevated expression of tumour necrosis
factor-α-induced protein 8 (TNFAIP8)-like 2 mRNA in peripheral
blood mononuclear cells is associated with disease progression of
acute-on-chronic hepatitis B liver failure. J Viral Hepat.
21:64–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li D, Song LJ, Fan Y, Li X, Li Y, Chen J,
Zhu F, Guo C, Shi Y and Zhang L: Down-regulation of TIPE2 mRNA
expression in peripheral blood mononuclear cells from patients with
systemic lupus erythematosus. Clin Immunol. 133:422–427. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Shao Z, Zhang X, Jia X, Xia Y,
Zhang Y, Xin N, et al: TIPE2 Play a Negative Role in TLR-Mediated
Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia
Gravis. J Neuroimmune Pharmacol. 10:635–644. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun H, Zhuang G, Chai L, Wang Z, Johnson
D, Ma Y and Chen YH: TIPE2 controls innate immunity to RNA by
targeting the phosphatidylinositol 3-kinase-Rac pathway. J Immunol.
189:2768–2773. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gus-Brautbar Y, Johnson D, Zhang L, Sun H,
Wang P, Zhang S, Zhang L and Chen YH: The anti-inflammatory TIPE2
is an inhibitor of the oncogenic Ras. Mol Cell. 45:610–618. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joung SM, Park ZY, Rani S, Takeuchi O,
Akira S and Lee JY: Akt contributes to activation of the
TRIF-dependent signaling pathways of TLRs by interacting with
TANK-binding kinase 1. J Immunol. 186:499–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goh FG and Midwood KS: Intrinsic danger:
Activation of Toll-like receptors in rheumatoid arthritis.
Rheumatology (Oxford). 51:7–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Drexler SK and Foxwell BM: The role of
toll-like receptors in chronic inflammation. Int J Biochem Cell
Biol. 42:506–518. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Diebold BA and Bokoch GM: Rho GTPases and
the control of the oxidative burst in polymorphonuclear leukocytes.
Curr Top Microbiol Immunol. 291:91–111. 2005.PubMed/NCBI
|
|
25
|
Niedergang F and Chavrier P: Regulation of
phagocytosis by Rho GTPases. Curr Top Microbiol Immunol. 291:43–60.
2005.PubMed/NCBI
|
|
26
|
Shi C, Zhang S, Hong S, Pang J, Yesibulati
Y, Yin P and Zhuang G: The pro-apoptotic effects of TIPE2 on AA rat
fibroblast-like synoviocytes via regulation of the
DR5-caspase-NF-κB pathway in vitro. Onco Targets Ther. 9:993–1000.
2016.PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arranz A, Gutiérrez-Cañas I, Carrión M,
Juarranz Y, Pablos JL, Martínez C and Gomariz RP: VIP reverses the
expression profiling of TLR4-stimulated signaling pathway in
rheumatoid arthritis synovial fibroblasts. Mol Immunol.
45:3065–3073. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang YH, Yan HQ, Wang F, Wang YY, Jiang
YN, Wang YN and Gao FG: TIPE2 inhibits TNF-α-induced hepatocellular
carcinoma cell metastasis via Erk1/2 downregulation and NF-kB
activation. Int J Oncol. 46:254–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kyburz D, Rethage J, Seibl R, Lauener R,
Gay RE, Carson DA and Gay S: Bacterial peptidoglycans but not CpG
oligodeoxynucleotides activate synovial fibroblasts by toll-like
receptor signaling. Arthritis Rheum. 48:642–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jung YO, Cho ML, Kang CM, Jhun JY, Park
JS, Oh HJ, Min JK, Park SH and Kim HY: Toll-like receptor 2 and 4
combination engagement upregulate IL-15 synergistically in human
rheumatoid synovial fibroblasts. Immunol Lett. 109:21–27. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakano K, Boyle D and Firestein G:
Regulation of DNA methylation in rheumatoid arthritis synoviocytes.
J Immunol. 190:1297–1303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ospelt C, Brentano F, Jüngel A, Rengel Y,
Kolling C, Michel BA, Gay RE and Gay S: Expression, regulation, and
signaling of the pattern-recognition receptor nucleotide-binding
oligomerization domain 2 in rheumatoid arthritis synovial
fibroblasts. Arthritis Rheum. 60:355–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Zhao X, Liu X and Liu H: Disruption
of TIM-4 in dendritic cell ameliorates hepatic warm IR injury
through the induction of regulatory T cells. Mol Immunol.
66:117–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Termeer C, Benedix F, Sleeman J, Fieber C,
Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C and Simon JC:
Oligosaccharides of Hyaluronan activate dendritic cells via
toll-like receptor 4. J Exp Med. 195:99–111. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sacre S, Medghalchi M, Gregory B, Brennan
F and Williams R: Fluoxetine and citalopram exhibit potent
antiinflammatory activity in human and murine models of rheumatoid
arthritis and inhibit toll-like receptors. Arthritis Rheum.
62:683–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ehrhardt C, Kardinal C, Wurzer WJ, Wolff
T, von Eichel-Streiber C, Pleschka S, Planz O and Ludwig S: Rac1
and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral
activation of interferon regulatory factor-3. FEBS Lett.
567:230–238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Okamura Y, Watari M, Jerud ES, Young DW,
Ishizaka ST, Rose J, Chow JC and Strauss JF III: The extra domain A
of fibronectin activates Toll-like receptor 4. J Biol Chem.
276:10229–10233. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hemmi H, Takeuchi O, Kawai T, Kaisho T,
Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K and
Akira S: A Toll-like receptor recognizes bacterial DNA. Nature.
408:740–745. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang H, Ouyang H, Wang D, Shi J, Ouyang
C, Chen H, Xiao S and Fang L: Mycobacterium tuberculosis Rv2185c
contributes to nuclear factor-κB activation. Mol Immunol.
66:147–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
